| abstract |
Inhibitors based on cyclin-dependent quinoline kinase 2, compositions including inhibitors, and methods of use of inhibitors and inhibitor compositions are described; the inhibitors and compositions that include them are useful for the treatment of a disease or symptoms of disease; The invention also provides methods for the preparation of CDK-2 inhibitor compounds, methods for inhibiting CDK-2, and methods for treating a disease or disease symptoms. |